Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed cultivator and  producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “Company” or  “Blueberries”), is pleased to report its financial results for the year ended December 31, 2020. Blueberries  has filed today its audited consolidated financial statements and related management’s discussion and  analysis, both of which are available on Blueberries’ profile at All financial information in  this press release is reported in Canadian dollars, unless otherwise indicated.

See more